Hemodynamics, Vascular Biology & Hypertension Secondary to Kidney Disease Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
New to F1000? See this week’s top article below for a free preview of a Recommendation.
- » Blood pressure measurement and circadian rhythm
- » Cortical blood flow, glomerular microcirculation and ultrafiltration
- » Diabetic nephropathy
- » Endothelial function
- » Epidemiology
- » Essential hypertension
- » Genomic, proteomic and bioinformatics
- » Medullary circulation
- » Metabolic syndrome, diabetes and hypertension
- » Reactive oxygen species, oxidative stress
- » Renin-angiotensin-aldosterone system
- » Salt and hypertension
- » Secondary hypertension
- » Sympathetic nerve system
- » Therapy, clinical trials
- » Vascular remodeling
- » Vascular smooth muscle cell function
- » Vasoactive peptide
Current therapy for diabetic nephropathy still primarily relies on the antiproteinuric, antihypertensive, and nephroprotective effects of renin-angiotensin system (RAS) blockers. However, these standard therapies are insufficient to prevent progression to end-stage renal disease (ESRD) in...
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
1 Recommendation, most recent by| Good for Teaching | Interesting Hypothesis | Systematic Review / Meta-analysis
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.